FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic CancerThierry Conroy, Jean‐Baptiste Bachet, Gilles Breysacher et al.|New England Journal of Medicine|2018Cited by 2.8k
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trialThierry Conroy, Jean‐Baptiste Bachet, Jean-François Bosset et al.|The Lancet Oncology|2021Cited by 1.3k
Cancer-associated fibroblast-derived annexin A6+ extracellular vesicles support pancreatic cancer aggressivenessJulie Leca, Richard Tomasini, Sébastien Martinez et al.|Journal of Clinical Investigation|2016Cited by 212
Current standards and new innovative approaches for treatment of pancreatic cancerThierry Conroy, Michel Ducreux, Jean‐Baptiste Bachet et al.|European Journal of Cancer|2016Cited by 186
Pacpaint: a histology-based deep learning model uncovers the extensive intratumor molecular heterogeneity of pancreatic adenocarcinomaCharlie Saillard, Jérôme Cros, F. Delecourt et al.|Nature Communications|2023Cited by 64